poisar

Stocks · News reference

Tandem Diabetes Care Reports Third Quarter 2026 Financial Results

Fiscal.ai

Tandem Diabetes Care reported third quarter 2026 sales of $283.7 million, exceeding analyst expectations, and reaffirmed its full-year 2026 guidance.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading